Loading...
NPI 1114264660 · Little Rock, AR · Public Health or Welfare Agency
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Arkansas Department Of Health Family Planning Clinic is a public health or welfare agency provider located in Little Rock, Arkansas. This profile covers 0 Medicare and 30 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Arkansas Department Of Health Family Planning Clinic |
| Address | 4815 W Markham St |
| City | Little Rock |
| State | AR |
| ZIP | 72205 |
| Taxonomy | Public Health or Welfare Agency |
| NPI Enumerated | January 3, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $15.6M |
| Medicare | $0 |
This entity is effectively a Medicaid-only billing provider: there is no Medicare revenue on file and its entire reported lifetime federal billing is Medicaid at $15.6M. The provider’s NPI was enumerated on 2013-01-03 (~13 years ago), indicating an established public-health clinic presence in Arkansas over the last decade-plus.
Revenue for this provider is highly concentrated in a narrow set of services: the top three Medicaid codes — 99402, 99401, and J7307 — together account for 52.0% of its total Medicaid revenue. Individually those codes are reported as 99402 $2.9M (18.9%), 99401 $2.9M (18.9%), and J7307 $2.2M (14.2%), signaling reliance on a small number of high-volume/high-value service lines.
The code mix strongly identifies a family-planning and sexual-health service line: high-volume counseling visits (99401 with 63.9K claims and 99402 with 45.3K claims), contraceptive device and implant procedures (J7307, J7298, J7297, 11981, 11976), and extensive STI and pregnancy screening (87491 and 87591 each 37.6K claims; 81025 with 59.1K claims). These volumes are consistent with a high-throughput public health clinic focused on contraception access and routine sexual-health screening.
Competitive standing in Arkansas is dominant for many core services: the provider ranks #1 in-state and at the 100th percentile for multiple key codes including 99402, 99401, 87491, 87591, 81025, and J1050, with the data labeling those positions as “extreme outlier” or equivalent. This pattern indicates the clinic is a major statewide delivery point for preventive counseling, STI testing, and contraceptive services compared with peers.
Not all high-volume codes are statistically atypical: some device-focused codes like J7307 (ranks #1 of 4; 100th percentile; labeled typical, unremarkable volume) and 11981 (ranks #1 of 4; typical, unremarkable) are characterized as expected given the provider’s service set. Additionally, a few tests and procedures fall in lower percentiles or mid-range ranks (for example 87661 at the 86th percentile and 99215 at the 43rd percentile), showing the provider’s dominance is concentrated in specific family-planning and sexual-health items rather than across every ambulatory code.
Operational scale is reflected in claim counts that imply very high patient throughput for preventive and reproductive services: examples include 63.9K claims for 99401, 59.1K claims for 81025 (pregnancy testing), 50.9K claims for J1050 (medroxyprogesterone injection), and 37.6K claims each for 87491 and 87591 (Chlamydia and Gonorrhea NAAT). Those volumes support a clinic model oriented to repeatable procedures, point-of-care testing, and frequent counseling encounters.
Revenue-per-claim patterns separate device and medication revenue from laboratory and screening revenue: implant and IUD device codes report higher avg paid/claim (e.g., J7307 $388 avg paid/claim, J7298 $335 avg paid/claim, J7297 $180 avg paid/claim) while high-volume lab and screening codes have much lower per-claim payments (e.g., 87491 and 87591 $45 avg paid/claim, 81025 $7 avg paid/claim). This mix helps explain how a relatively modest per-test payer rate can still produce substantial aggregate revenue when paired with very large claim counts.
Several procedure codes appear with no direct state peer comparison (ranked as the only reporting provider), including intrauterine device placement/removal and certain implant insertion/removals (58300, 58301, 11976, 11982, J7300). Those single-provider rankings suggest either unique service delivery within the Medicaid dataset or specialized reporting relationships for IUD and implant procedures at this public health clinic.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
30 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99402 | At an encounter separate from a preventive medicine visit, the provider offers counseling related to subjects appropriate for the patient’s age, family history, and areas of concern. The subjects… | 45,340 | $70 | $2.9M |
| 99401 | At an encounter separate from a preventive medicine visit, the provider offers counseling related to subjects appropriate for the patient’s age, family history, and areas of concern. The subjects… | 63,940 | $50 | $2.9M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 5,690 | $390 | $2.2M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 37,620 | $50 | $1.7M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 37,590 | $50 | $1.7M |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 50,910 | $20 | $967.3K |
| 11981 | The provider inserts a bioresorbable, biodegradable, or non–biodegradable implant, such as a capsule or pellet, containing a drug for long–term delivery. | 5,660 | $150 | $837.7K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 19,340 | $30 | $580.3K |
| 81025 | The lab analyst performs the pregnancy test on a urine specimen using a methodology or kit that the analyst can read visually for a direct readout. | 59,050 | $10 | $413.4K |
| 58300 | In this procedure, the provider places a contraceptive intrauterine device (IUD) in the uterine cavity. | 2,840 | $90 | $241.7K |
Showing 1–10 of 30
How this provider's Medicaid billing volume and revenue compare to other Arkansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arkansas median
30 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 1 | 10 | 440 | $420 | $698K |
| 58300 | In this procedure, the provider places a contraceptive intrauterine device (IUD) in the uterine cavity. | 1 | 10 | 2,840 | $90 | $242.5K |
| 99402 | At an encounter separate from a preventive medicine visit, the provider offers counseling related to subjects appropriate for the patient’s age, family history, and areas of concern. The subjects… | 1 | 10 | 100 | $50 | $241.2K |
| 11981 | The provider inserts a bioresorbable, biodegradable, or non–biodegradable implant, such as a capsule or pellet, containing a drug for long–term delivery. | 1 | 10 | 110 | $140 | $212.9K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 1 | 70 | 830 | $40 | $146.4K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 1 | 70 | 830 | $40 | $144.9K |
| 11976 | Contraceptive capsules (e.g. Levonorgestrel) are inserted subdermally, under the patient's arm skin. These capsules then release levels of synthetic hormones to prevent pregnancy. These capsules… | 1 | 10 | 1,420 | $90 | $124.2K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 1 | 10 | 360 | $340 | $121.7K |
| J7300 | Intrauterine copper contraceptive (paragard) | 1 | 10 | 490 | $230 | $114.2K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 5 | 30 | 400 | $40 | $112.1K |
Showing 1–10 of 30
Other providers in the same ZIP code as Arkansas Department Of Health Family Planning Clinic, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.